Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Gino

Gino Bancalari, Bristol GB

Patent application numberDescriptionPublished
20100138005PROCESS CONTROL OF TOLERANCE RINGS - A method of process control including constraining a tolerance ring relative to one of an inner and an outer component. The tolerance ring including an annular band of resilient material having a plurality of projections projecting radially therefrom. Additionally, the method includes moving the other of the inner or outer component with respect to the constrained tolerance ring so as to compress the projections of the tolerance ring between the inner and outer components, and continuing movement of the inner or outer component, respectively, beyond the projections. The method further including measuring a force required for continuing movement, and using the force for process control.06-03-2010

Gino Boussiengui-Boussiengui, Libreville GA

Patent application numberDescriptionPublished
20120180161Method of Modifying the Carbohydrate Content of a Plant - A method of modifying at least one carbohydrate in a tissue of a plant is described. The method is typically applied to a sugarcane plant of the genus 07-12-2012

Gino Bradica, Claremont, NH US

Patent application numberDescriptionPublished
20110112655DEVICE FOR REGENERATION OF ARTICULAR CARTILAGE AND OTHER TISSUE - An implantable device for facilitating the healing of voids in bone, cartilage and soft tissue is disclosed. A preferred embodiment includes a cartilage region comprising a polyelectrolytic complex joined with a subchondral bone region. The cartilage region, of this embodiment, enhances the environment for chondrocytes to grow articular cartilage; while the subchondral bone region enhances the environment for cells which migrate into that region's macrostructure and which differentiate into osteoblasts. A hydrophobic barrier exists between the regions, of this embodiment. In one embodiment, the polyelectrolytic complex transforms to hydrogel, following the implant procedure.05-12-2011

Gino Bradica, Ewing, NJ US

Patent application numberDescriptionPublished
20120191130System and devices for the repair of a vertebral disc defect - A system for repairing a vertebral disc defect, such as hernia or bulge, a full or partial tear in the annulus, or a weakened annulus wall as a result of an excision procedure. The system introduces a treatment device arranged to repair the defect, and may prevent the leakage of fluid from the nucleus. The components of the device may be resorbable materials, and may induce the ingrowth of cellular material into the components. The system may feature a locating device to ensure proper placement of the treatment device.07-26-2012

Gino Bradica, Mullica Hill, NJ US

Patent application numberDescriptionPublished
20100331865Biphasic implant device providing joint fluid therapy - Tissue implants prepared for the repair of tissues, especially avascular tissues such as cartilage. One embodiment presents an electric potential capable of receiving and accumulating desirable factors or molecules from surrounding fluid when exposed to dynamic loading. In another embodiment the implant promotes tissue conduction by retarding, restricting and controlling cellular invasion through use of gradients until competent tissue forms. Further embodiments of the tissue implants may be formed into a multi-phasic device that provides deep tissue mechanical stimulus by conduction of mechanical and fluid forces experienced at the surface of the implant.12-30-2010

Gino Bradioa, Mullica Hill, NJ US

Patent application numberDescriptionPublished
20100330181Biphasic implant device providing gradient - Tissue implants prepared for the repair of tissues, especially avascular tissues such as cartilage. One embodiment presents an electric potential capable of receiving and accumulating desirable factors or molecules from surrounding fluid when exposed to dynamic loading. In another embodiment the implant promotes tissue conduction by retarding, restricting and controlling cellular invasion through use of gradients until competent tissue forms. Further embodiments of the tissue implants may be formed into a multi-phasic device that provides deep tissue mechanical stimulus by conduction of mechanical and fluid forces experienced at the surface of the implant.12-30-2010

Gino Burro, Zurich CH

Patent application numberDescriptionPublished
20090121829Method, Electronic Cover, and Access Unit for Providing Access to a Zone by Means of a Card - An access system includes a portable pouch and an access unit. The pouch has an inserted electronic card, a card receive module and a send/receive module. The access unit is assigned to a transit region of the zone and has a send/receive unit for a communication with the send/receive module of the pouch. To provide access, the tag is transmitted to the send/receive unit of the access unit when the pouch is within range of the send/receive unit. If the tag received by the send/receive unit matches a stored tag, an unblocking signal for providing access to the zone is generated. A signal detector of the pouch detects an electromagnetic field generated by a send unit arranged in the transit region, and information transmitted by the electromagnetic field is processed. A bidirectional communication between the send/receive unit of the access unit and the send/receive module of the pouch is initiated.05-14-2009

Gino Cicchello, Vernon Hills, IL US

Patent application numberDescriptionPublished
20090008306EXTRACORPOREAL DIALYSIS READY PERITONEAL DIALYSIS MACHINE - A dialysis system includes: (i) a dialysate pump; (ii) a patient line having a connector configured to be attached to a peritoneal patient part; (iii) an extracorporeal circuit; (iv) a blood pump in fluid communication with the extracorporeal circuit; (v) a blood filter in fluid communication with the extracorporeal circuit; and (vi) a control unit configured and arranged to selectively perform a therapy which (a) the blood pump is deactivated and the dialysate pump is caused to pump dialysate through the patient line or (b) the blood pump is activated to pump blood to the blood filter and the dialysate pump is caused to pump dialysate to the filter/extracorporeal circuit and/or remove fluid from the filter.01-08-2009
20090012450EXTENDED USE DIALYSIS SYSTEM - A medical fluid machine, such as a dialysis machine, includes a pump that pumps a medical fluid and sterile water or other disinfecting liquid, such as ozonated water, for flushing and reconditioning the medical fluid machine. The machine may also include a heater that heats the medical fluid or disinfecting solution in order to kill bacteria and other microorganisms that may contaminate the machine after use. Disinfecting the machine, and a disposable kit used with the machine, may allow re-use of the disposable within a reasonable amount of time after completion of the disinfecting procedure. Dialysate treated with ultra-violet light or water with low concentrations of ozone also helps make the disposable kits suitable for reuse.01-08-2009

Gino Colonico, Georgetown CA

Patent application numberDescriptionPublished
20080292746Valve Pin Bushing Having Thermally Insulative Component - A valve pin bushing for a hot runner includes a bushing body having a hole therethrough for receiving a valve pin and a rearward surface for contacting a back plate. A thermally insulative component is coupled to a forward surface of the bushing body. The thermally insulative component is made of a nonmetallic material having a thermal conductivity lower than that of the bushing body.11-27-2008

Gino Cuglietta, Kanata CA

Patent application numberDescriptionPublished
20080310789Method of Changing the Birefringence of an Optical Waveguide by Laser Modification of the Cladding - A method of inducing birefringence in an optical waveguide is disclosed wherein the waveguide cladding is irradiated with energy of a sufficient intensity so as to induce a stress in the optical waveguide so as to cause a multitude of spaced stress induced regions within the cladding of the optical waveguide such that there are 10 to 5000 spaced regions per mm and wherein the stress induced regions are proximate the core greater than 2 microns distance from the core-cladding interface. This waveguide has numerous uses, for example a fiber sensor.12-18-2008
20090041405Ridge waveguide optical sensor incorporating a Bragg grating - An optical sensor for sensing information relating to an analyte liquid or gas, has a a planar substrate having a refractive index n02-12-2009
20090317928HIGH TEMPERATURE STABLE FIBER GRATING SENSOR AND METHOD FOR PRODUCING SAME - A method of producing a thermally stable grating allows the grating to be placed in environments where temperatures reach 1000° C. and where the grating is relatively stable and has very low loss from scatter. These gratings have spectral characteristics that allow them to be concatenated so as to form a sensor array. The method requires a step of lowering the characteristic intensity threshold of a waveguide by at least 25%, followed by irradiating the waveguide with femtosecond pulses of light having a sufficient intensity and for a sufficient duration to write the grating so that at least 60% of the grating remains after exposures of at least 10 hours at a temperature of at least 1000° C. Pre-writing a Type I grating before writing a minimal damage Type II grating lowers the characteristic threshold of the waveguide so that a stable low damage type II grating can be written; alternatively providing a hydrogen or deuterium loaded waveguide before writing the grating lowers the characteristic threshold of the waveguide.12-24-2009
20120324959HIGH TEMPERATURE STABLE FIBER GRATING SENSOR AND METHOD FOR PRODUCING SAME - A method of producing a thermally stable grating allows the grating to be placed in environments where temperatures reach 1000° C. These gratings may be concatenated so as to form a sensor array. The method requires a step of lowering the characteristic intensity threshold of a waveguide by at least 25%, followed by irradiating the waveguide with femtosecond pulses of light having a sufficient intensity and for a sufficient duration to write the grating so that at least 60% of the grating remains after exposures of at least 10 hours at a temperature of at least 1000° C. Pre-writing a Type I grating before writing a minimal damage Type II grating lowers the characteristic threshold of the waveguide so that a stable low damage type II grating can be written; alternatively providing a hydrogen or deuterium loaded waveguide before writing the grating lowers the characteristic threshold of the waveguide.12-27-2012

Patent applications by Gino Cuglietta, Kanata CA

Gino De-Gol, Warwick GB

Patent application numberDescriptionPublished
20090084285Carnival Ride - The carnival ride has a travel path for cars with seats and at least one screen arranged adjacent to the travel path. In order to design the carnival ride in such a way that the passengers in the car have an optimal gaming experience, the screen follows the car at least along a section of its travel distance. In this way, the passengers in the car have a very long-lasting visual contact with the screen or with the movie shown on the screen.04-02-2009
20090181781Amusement Ride - An amusement ride has guides and at least one carriage movable along the guides. At least three first arms each having a first end and a second end are provided, wherein the first ends are connected pivotably to the at least one carriage. First drives are provided that each are movable along one of the guides, respectively, independently from one another. The at least three first arms are pivotably connected with the second ends to the first drives so that the at least one carriage and the first drives are pivotably connected to one another.07-16-2009

Gino Disimone, Reno, NV US

Patent application numberDescriptionPublished
20080223926BIOMETRIC CONTROL OF EQUIPMENT - An example apparatus for allowing operation of equipment by an authorized operator comprises a biometric scanner receiving a biometric input from an authorized operator, and transmitting an authorization signal. The apparatus may further includes a base station that allows the equipment to operate while the base station receives the authorization signal from the biometric scanner, and which prevents the equipment from operating shortly after the authorization signal is no longer received from the biometric scanner.09-18-2008
20080229409CONTROL OF EQUIPMENT USING REMOTE DISPLAY - An example display unit for facilitating operation of equipment includes a housing, an electronic display supported by the housing, and an electronic circuit located within the housing. The display unit may include one or more data receivers, such as a wireless receiver and/or an electrical interface. A biometric scanner, including a biometric sensor and proving an authorization signal when an authorized biometric input is detected by the biometric sensor, may be configured to electrically (and optionally mechanically) interconnect to the display unit. The example display unit receives an authorization status for operation of the equipment from the biometric scanner, and displays the authorization status and operational parameters relating to equipment use on the electronic display.09-18-2008

Gino Dompietro, Victoria AU

Patent application numberDescriptionPublished
20100312618Transaction System for Use in Authorising Cashless Transactions - A transaction system, including: an entry system for reading first identification data from a first device and second identification data from a second device; and a database system for accessing payment account data of a transaction account on the basis of the first and second identification data, and requesting authorisation data for a payment transaction using the payment account data. The entry system performs an authorisation process in response to the authorisation data being received. The database system stores an authorisation record with an authorisation time in response to the authorisation data being received. A payment system can be used to read the second identification data from the second device and generate payment data representing a payment amount. The database system then determines authorisation for a payment transaction on the basis of the second identification data and the authorisation record, and in response submits the payment data and the payment account data to a payment processing system for performing the payment transaction.12-09-2010

Gino D'Ovidio, L'Aquila IT

Patent application numberDescriptionPublished
20080283116LIGHT ENERGY CONVERSION SYSTEMS AND METHODS - A light energy conversion (LEC) system includes a fluid circuit having a working fluid flowing therethrough and a plurality of light concentrating (LC) modules for converting light energy into electrical energy and for transforming the light energy into thermal energy. The LC modules including a first LC module coupled in series with a second LC module along the fluid circuit. The working fluid absorbs thermal energy while flowing through the first and second LC modules. At least the first LC module includes a light concentrating optical element that is configured to direct light energy toward a focal region and a receiver held at the focal region. The receiver includes a housing having a chamber that holds an energy conversion member. The energy conversion member transforms light energy received from the optical element into electrical and thermal energy.11-20-2008
20090159115Light Concentrating Modules, Systems and Methods - A light concentrating module for transforming light into at least one of electrical and thermal energy is provided. The light concentrating module may be coupled in flow communication with a fluid conversion module and include a primary optical element that has a reflective surface with a plurality of contoured sections. Each contoured section is shaped to reflect light that impinges the contoured section toward a corresponding focal region. The module may also have a receiver system that includes a plurality of energy conversion members positioned proximate to corresponding focal regions. The receiver system also has a working fluid passage for carrying a working fluid that absorbs the thermal energy. The working fluid can be conveyed away from the receiver system through a mounting post that holds the receiver system. In addition, the module may also generate electricity.06-25-2009
20110094565METHODS, SYSTEMS, AND APPARATUSES FOR ALIGNING LIGHT CONCENTRATOR COMPONENTS WITH A LIGHT SOURCE - A tracking system configured to orient light concentrators to face a light source. The system includes a movable support structure for providing global alignment of the light concentrators with the light source. The system also includes a light concentrator (LC) module that is coupled to the support structure and has an array of light concentrators that are in fixed positions with respect to each other. The system also includes a secondary alignment mechanism having a module joint that movably couples the LC module to the support structure and an actuator assembly. The actuator assembly is configured to selectively move the LC module about two axes relative to a pivot point of the module joint thereby orienting the array of light concentrators.04-28-2011

Patent applications by Gino D'Ovidio, L'Aquila IT

Gino Figurelli, Denver, CO US

Patent application numberDescriptionPublished
20100200293HEATED GLASS PANELS - A glass panel assembly includes a glass sheet having an electro-conductive film provided thereon. A conductor having a thickness of at least about 0.15 mm is positioned on the electro-conductive film. An electrically conductive adhesive is provided between the conductor and the electro-conductive film. A retainer engages an edge portion of the glass sheet and the conductor. The retainer applies a compressive pressure to the conductor, the compressive pressure enhancing electrical contact between the conductor and the electro-conductive film.08-12-2010
20110017725HEATED LAMINATED GLASS PANELS - A heated laminated assembly includes a first layer having an electro-conductive film provided thereon. A first conductor having a thickness of at least 0.15 mm is positioned on the electro-conductive film. A second conductor having a thickness of at least 0.15 mm is positioned on the electro-conductive film in spaced-apart relation to the first conductor. A second layer is positioned on the electro-conductive film between the first conductor and the second conductor. A third layer is positioned on the second layer.01-27-2011

Patent applications by Gino Figurelli, Denver, CO US

Gino Garbellini, Melbourne AU

Patent application numberDescriptionPublished
20110273304TELEMETRY SYSTEM AND APPARATUS - An apparatus for receiving information at a location and communicating at least a subset of said information to a second location comprising an energy module; a communications module; and a data module.11-10-2011

Gino Giannaccini, Forte Dei Marmi (lu) IT

Patent application numberDescriptionPublished
20120309794COMPOUNDS INHIBITORS OF ENZYME LACTATE DEHYDROGENASE (LDH) AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS - The present invention concerns compounds, some of which are novel, and their pharmaceutical applications. The compounds of the invention inhibit the enzyme lactate dehydrogenase (LDH) involved both in the metabolic process of hypoxic tumour cells, and in the process used by parasitic protozoa that cause malaria to obtain most of the energy they need.12-06-2012

Gino Kronfle, Guayas EC

Patent application numberDescriptionPublished
20090108019ICE CREAM PACKAGING - The ice cream packaging of the present invention is a laminate thermal packaging capable of retaining cooler temperatures within the packaging for an extended period of time. Use of the packaging of the present invention, permits the ice cream to retain better physical, chemical and organoleptic properties. The packaging comprises layers of olefins, such as a polypropylene including a bi axially oriented polypropylene. One of the layers comprises a metallized bi axially oriented polypropylene containing aluminum. The present invention also provides a method of vending ice cream using the packaging of the present invention.04-30-2009

Gino Morrelli, Newport Beach, CA US

Patent application numberDescriptionPublished
20130023169Tri-Hulled Stand-Up Paddle Board - A trimaran standup paddleboard includes a main hull having a bow, a mid-beam and a stern. The main hull has a length and shape that extends from a point at the bow, broadens out to the mid-beam, and narrows to a point at the stern. The trimaran standup paddleboard further includes a platform on top and aft the main hull, the platform being planar and extending out sideways beyond the mid-beam of the main hull, and a pair of lateral struts extending laterally out from opposing sides of the main hull behind the platform from a proximal end of each lateral strut. The trimaran standup paddleboard further includes a pair of outrigger hulls, each outrigger hull being connected to a distal end of one of the pair of lateral struts, and positioned parallel with and spaced apart from the main hull aft the platform.01-24-2013

Gino Noe', Marghera (ve) IT

Patent application numberDescriptionPublished
20120220188TOY WITH ROTATING BALLS - A toy according to the invention includes a substantially linear rigid grip to which two spacers are hinged, each one of the spacers being provided with a small ball at an equal and constant distance from the grip and rotating around the grip in such a way that the two small balls rotate around the grip. Each spacer is provided with stop elements suited to limit the rotation of the spacers, to transfer the quantity of motion to the other spacer and to prevent contact between the two small balls. Support elements are provided for the application or insertion of a cardboard element aligned with the rotation axis of the spacers.08-30-2012

Gino Pagluica, Wells, ME US

Patent application numberDescriptionPublished
20110130246MOUNTING SYSTEM FOR A PLANATARY GEAR TRAIN IN A GAS TURBINE ENGINE - A mounting system for a planetary gear train in a gas turbine engine comprises a support strut, a deflection flange and a deflection limiter. The support strut extends between a stationary engine case and a rotating engine shaft that provides input to the planetary gear train in the gas turbine engine. The deflection flange extends from a rotating output component of the planetary gear train. The deflection limiter is connected to the support strut and engages the deflection flange when the gear train becomes radially displaced.06-02-2011

Gino Paonessa, Oakville CA

Patent application numberDescriptionPublished
20090172976SNOW PLOW ASSEMBLY WITH RESILIENT SNOW PLOW BLADE MOUNTING STRUCTURE - A snow plow assembly with a longitudinally extending plow body has a blade mounting structure that supports a longitudinally extending plow blade. The blade mounting structure has a series of hinges that receive a longitudinally extending pivot rod to couple the plow body to the snow blade and set of springs to bias the snow plow blade into an operative position and to resiliently restore the snow plow blade to the operative position after encountering an obstacle. The hinge portions fixed to the snow plow body each have a receiving slot to slidingly receive a hinge key and the hinge keys define a bearing surface for abutting one end of the coil spring. A locating notch is provided in the hinge keys to limit relative movement between a hinge key an associated hinge portion. A hinge lock to capture the pivot rod is also provided.07-09-2009
20110314708SNOW PLOW ASSEMBLY WITH RESILIENT SNOW PLOW BLADE MOUNTING STRUCTURE - A snow plow assembly with a longitudinally extending plow body has a blade mounting structure that supports a longitudinally extending plow blade. The blade mounting structure has a series of hinges that receive a longitudinally extending pivot rod to couple the plow body to the snow blade and set of springs to bias the snow plow blade into an operative position and to resiliently restore the snow plow blade to the operative position after encountering an obstacle. The hinge portions fixed to the snow plow body each have a receiving slot to slidingly receive a hinge key and the hinge keys define a bearing surface for abutting one end of the coil spring. A locating notch is provided in the hinge keys to limit relative movement between a hinge key an associated hinge portion. A hinge lock to capture the pivot rod is also provided.12-29-2011
20120017473Snow plow for adjusting to surface contours and obstacles - A snow plow includes a plurality of surface-engaging sections movably carried by the moldboard and depending from the moldboard in side-by-side relationship with one another. The surface-engaging sections are each independently linearly movable relative to the moldboard between an extended position and a retracted position to adjust to the contour of the surface being plowed. Each surface-engaging section comprises a main body portion carried by the moldboard, and a surface-engaging trip blade portion carried by the main body portion and which can pivot between a surface-scraping position and a deflected position and is urged toward the surface-scraping position. The trip blade portion can deflect to accommodate obstacles, and can cooperate with the linear movement of the surface-engaging sections to accommodate larger obstacles than can be accommodated by deflection alone. The snow plow also includes adjustable wear shoes and an adjustable vehicle mounting assembly.01-26-2012

Patent applications by Gino Paonessa, Oakville CA

Gino Regalli, Montgomery, OH US

Patent application numberDescriptionPublished
20100048519METHODS OF TREATMENT FOR ULCERATIVE COLITIS USING AMINOSALICYLATE - Disclosed herein is a new treatment for ulcerative colitis in male mammalian subjects. Further disclosed are increased dosages of an aminosalicylate composition for treatment of moderate ulcerative colitis in male mammalian subjects.02-25-2010
20100305076METHODS OF TREATMENT FOR ULCERATIVE COLITIS - Disclosed herein are new treatments for moderate ulcerative colitis in various subject subgroups. The various subject subgroups include Caucasians, non-smokers, subjects under the age of about 65 years, and subjects previously or currently being treated with steroids.12-02-2010

Gino Rigotti, S. Floriano IT

Patent application numberDescriptionPublished
20130046383METHOD AND DEVICES FOR TISSUE EXPANSION - A device for maintaining or achieving soft tissue expansion applicable to any body region already temporarily expanded including: an adhesive element deformable and capable of adapting to the shape of this body region, and which can then itself become mechanically rigid enough to resist tendency of the expanded tissue to recoil or to which a second material can be applied to form a stent adapted to the shape of the body area to provide the necessary structural rigidity to prevent recoil of the expansion and thereby induce its retention of its expanded shape after the stent is removed.02-21-2013

Gino Rigotti, San Pietro In Cariano (verona) IT

Patent application numberDescriptionPublished
20080300681BIOLOGICAL TISSUE GROWTH THROUGH INDUCED TENSILE STRESS - A tissue expansion device implanted in a non-activated state over a region of desired tissue growth. Once implanted and positioned the device is activated creating a supporting structure that creates a convex shaped dome over the underlying tissue. The convex shaped dome formed by the tissue expansion device places a tensile stress against the underlying tissue that promotes tissue growth. Alone or with the introduction of tissue enhancing agents and/or adipose tissue, new tissue within the convex shaped void grows until a balance is achieved eliminating the induced stress. Periodically the tissue expansion devices is again activated and enlarged creating an even larger void. Again, the newly enlarged void places additional tensile stress on the underlying tissue thus repeating the cycle of new tissue growth. Once the desired amount of tissue growth has been achieved the device is deactivated and removed.12-04-2008
20090181104BREAST RECONSTRUCTION OR AUGMENTATION USING COMPUTER-MODELED DEPOSITION OF PROCESSED ADIPOSE TISSUE - A tissue transfer method for reconstruction and augmentation of soft tissue. The method includes harvesting adipose tissue from a patient. The harvested tissue is processed via centrifugation to isolate a purified subset of the adipose tissue including separating and removing a substantial amount of triglycerides from the harvested adipose tissue. The centrifugation may be performed to cause separation of water from the purified adipose tissue and to cause separation of oil from mature adipocytes. Specifically, the spin rates may be selected to be high enough to cause lesions in the mature adipocytes that results in the release of the oil. The method continues with implanting the purified adipose tissue into the patient at a breast or other area identified for reconstruction or augmentation. The implanting is performed based on an injection pathway model that defines injection point locations and a number of injection pathway directions from each point.07-16-2009

Gino Rigotti, Verona IT

Patent application numberDescriptionPublished
20100160948BIOLOGICAL TISSUE GROWTH THROUGH INDUCED TENSILE STRESS - A tissue expansion device implanted in a non-activated state over a region of desired tissue growth. Once implanted and positioned the device is activated creating a supporting structure that creates a convex shaped dome over the underlying tissue. The convex shaped dome formed by the tissue expansion device places a tensile stress against the underlying tissue that promotes tissue growth. Alone or with the introduction of tissue enhancing agents and/or adipose tissue, new tissue within the convex shaped void grows until a balance is achieved eliminating the induced stress. Periodically the tissue expansion devices is again activated and enlarged creating an even larger void. Again, the newly enlarged void places additional tensile stress on the underlying tissue thus repeating the cycle of new tissue growth. Once the desired amount of tissue growth has been achieved the device is deactivated and removed.06-24-2010
20100161052BIOLOGICAL TISSUE GROWTH THROUGH INDUCED TENSILE STRESS - A tissue expansion device implanted in a non-activated state over a region of desired tissue growth. Once implanted and positioned the device is activated creating a supporting structure that creates a convex shaped dome over the underlying tissue. The convex shaped dome formed by the tissue expansion device places a tensile stress against the underlying tissue that promotes tissue growth. Alone or with the introduction of tissue enhancing agents and/or adipose tissue, new tissue within the convex shaped void grows until a balance is achieved eliminating the induced stress. Periodically the tissue expansion devices is again activated and enlarged creating an even larger void. Again, the newly enlarged void places additional tensile stress on the underlying tissue thus repeating the cycle of new tissue growth. Once the desired amount of tissue growth has been achieved the device is deactivated and removed.06-24-2010
20100168780BIOLOGICAL TISSUE GROWTH THROUGH INDUCED TENSILE STRESS - A tissue expansion device implanted in a non-activated state over a region of desired tissue growth. Once implanted and positioned the device is activated creating a supporting structure that creates a convex shaped dome over the underlying tissue. The convex shaped dome formed by the tissue expansion device places a tensile stress against the underlying tissue that promotes tissue growth. Alone or with the introduction of tissue enhancing agents and/or adipose tissue, new tissue within the convex shaped void grows until a balance is achieved eliminating the induced stress. Periodically the tissue expansion devices is again activated and enlarged creating an even larger void. Again, the newly enlarged void places additional tensile stress on the underlying tissue thus repeating the cycle of new tissue growth. Once the desired amount of tissue growth has been achieved the device is deactivated and removed.07-01-2010

Gino Ringuette, Saint-Catherine CA

Patent application numberDescriptionPublished
20120225244ABSORBENT SHEET PRODUCTS AND METHOD FOR FOLDING SAME - A stack of interfolded absorbent sheet products comprising a plurality of absorbent sheets and a method of folding and stacking the same. Each one of the absorbent sheets is folded twice about a first axis to define two inwardly folded inner panels and at least once about a second axis to define at least two outer panels sandwiching the inner panels therebetween. The second axis is substantially perpendicular to the first axis, Each of the absorbent sheet products comprises at least one outer panel at least partially sandwiched between a pair of outer panels of an adjacent one of the absorbent sheet products of the stack. Each one of the absorbent sheet products is entirely detached from all other absorbent sheet products of the stack.09-06-2012

Gino Sirejacob, Evergem BE

Patent application numberDescriptionPublished
20090087646COATED SUBSTRATE, COMPOSITION FOR TREATING A SUBSTRATE AND PROCESS OF TREATMENT - A siliceous substrate having at least a portion of a face which is provided with a water-repellent fluoro silane layer substantially equally distributed at a fluoro silane coating rate comprised between 2 mg/m04-02-2009

Gino Van Heeke, Horsham GB

Patent application numberDescriptionPublished
20100190714RNAi Inhibition of Alpha-ENaC Expression - The invention relates to compositions and methods for modulating the expression of alpha-ENaC, and more particularly to the downregulation of alpha-ENaC expression by chemically modified oligonucleotides.07-29-2010
20100210513RNAi Inhibition of Alpha-ENaC Expression - The invention relates to compositions and methods for modulating the expression of alpha-ENaC, and more particularly to the downregulation of alpha-ENaC expression by chemically modified oligonucleotides.08-19-2010
20100210514RNAi Inhibition of Alpha-ENaC Expression - The invention relates to compositions and methods for modulating the expression of alpha-ENaC, and more particularly to the downregulation of alpha-ENaC expression by chemically modified oligonucleotides.08-19-2010
20100216971RNAi Inhibition of Alpha-ENaC Expression - The invention relates to compositions and methods for modulating the expression of alpha-ENaC, and more particularly to the downregulation of alpha-ENaC expression by chemically modified oligonucleotides.08-26-2010
20100216972RNAi Inhibition of Alpha-ENaC Expression - The invention relates to compositions and methods for modulating the expression of alpha-ENaC, and more particularly to the downregulation of alpha-ENaC expression by chemically modified oligonucleotides.08-26-2010

Gino Van Heeke, Upper Beeding GB

Patent application numberDescriptionPublished
20090156529RNAi Inhibition of Alpha-ENaC Expression - The invention relates to compositions and methods for modulating the expression of alpha-ENaC, and more particularly to the downregulation of alpha-ENaC expression by chemically modified oligonucleotides.06-18-2009
20120183549CHEMOKINE RECEPTOR BINDING POLYPEPTIDES - The present invention relates to polypeptides directed against or specifically binding to chemokine receptor CXCR2 and in particular to polypeptides capable of modulating signal transduction from CXCR2. The invention also relates to nucleic acids, vectors and host cells capable of expressing the polypeptides of the invention, pharmaceutical compositions comprising the polypeptides and uses of said polypeptides and compositions for treatment of diseases involving aberrant functioning of CXCR2.07-19-2012

Gino Villetti, Parma IT

Patent application numberDescriptionPublished
20080287480Therapeutic Combination Comprising a Nmda Receptors Blocker and a Narcotic Analgesic Substance - The invention relates to a medicament comprising a combination of a substance that blocks both the ion channel associated to NMDA receptors and MAO enzymes and a narcotic analgesic substance, preferably a fixed combination, pharmaceutical compositions thereof, and to the use thereof for the treatment of subjects suffering of various types of pain and/or for inhibiting the development of tolerance, and/or physical dependence on a narcotic analgesic substance.11-20-2008
20090005364Azole Derivatives With Antimuscarinic Activity - The present invention relates to compounds of formula (I) wherein R1, R2, x, X, Y and B are as defined in the description for the treatment of muscarinic acetylcholine receptor mediated diseases, in particular M3 muscarinic receptor mediated diseases.01-01-2009
20090170903ESTER DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS - The invention provides inhibitors of the phosphodiesterase 4 (PDE4) enzyme. More particularly, the invention relates to compounds that are new ester derivatives, methods of preparing such compounds, compositions containing them, and therapeutic uses thereof.07-02-2009
20090186033ANTI-AMYLOID IMMUNOGENIC COMPOSITIONS, METHODS AND USES - The present invention provides a recombinant immunogenic obtained by tandem multimerization of a B-cell epitope bearing fragment of Aβ42, within the active loop site of a carrier (display site), preferably bacterial thioredoxin (Trx). Polypeptides bearing multiple copies of Aβ42 fragments, preferably with an interposed amino acid linker, were constructed and injected into mice in combination with an adjuvant. Monoclonal antibodies were made which recognize the immunogenic construct comprising a carrier bearing at least one fragment of Aβ42 within an active loop site of the carrier. The elicited antibodies were found to selectively bind to fibrillar and/or oligomers Aβ within neuritic AD plaques.07-23-2009
20100028353ANTI-AMYLOID IMMUNOGENIC COMPOSITIONS, METHODS AND USES - Polypeptide based on a tandem array of repeats of the N-terminal 7 amino acids of Aβ42, preferably positioned within the active loop site of a carrier such as bacterial thioredoxin (Trx) are useful for treating and/or preventing Alzheimer's disease. Antibodies raised against these recombinant constructs were found to have a very strong affinity for Aβ42.02-04-2010
201000997681-PHENYLALKANECARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES - 1-Phenylalkanecarboxylic acid derivatives, the processes for the preparation thereof and the use thereof in the treatment and/or prevention of neurodegenerative diseases such as Alzheimer's disease.04-22-2010
201102637111-(2-FLUOROBIPHENYL-4-YL)-ALKYL CARBOXYLIC ACID DERIVATIVES FOR THE THERAPY OF TRANSTHYRETIN AMYLOIDOSIS - Derivatives of 1-(2-fluorobiphenyl-4-yl)-alkyl carboxylic acid are capable of stabilizing the tetrameric native state of transthyretin for the prophylaxis and treatment of amyloidosis.10-27-2011
201102881751-PHENYLALKANECARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES - 1-Phenylalkanecarboxylic acid derivatives, the processes for the preparation thereof and the use thereof in the treatment and/or prevention of neurodegenerative diseases such as Alzheimer's disease.11-24-2011
201200221631-(2-FLUOROBIPHENYL-4-YL)-CYCLOPROPANECARBOXYLIC ACID DERIVATIVES FOR THE THERAPY OF PRION DISEASES - Derivatives of 1-(2-fluorobiphenyl-4-yl)-cyclopropanecarboxylic acid are useful for the prevention and/or treatment of prion diseases in animals and humans.01-26-2012

Patent applications by Gino Villetti, Parma IT